FSD Pharma Appoints Larry Kaiser, MD, FACS, Dean, Lewis Katz School of Medicine at Temple University as Chairman of Its Scientific Advisory Board Cannabis Investing News
Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis in a Recent Idiopathic Pulmonary Fibrosis Study by 56% Life Science Investing
Life Science Big News Roundup: Lexaria and Hill Street Enter Global Manufacturing & Licensing Partnership; Cardiol to Present at Canaccord Genuity 39th Annual Growth Conference Life Science Investing
Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union Pharmaceutical Investing
Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference Cannabis Investing News
Cytokinetics Granted European Orphan Designation for Reldesemtiv to Treat Spinal Musclar Atrophy Biotech Investing
La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118 Pharmaceutical Investing
Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor Pharmaceutical Investing
